SE9803272D0 - A drug for cell regeneration - Google Patents

A drug for cell regeneration

Info

Publication number
SE9803272D0
SE9803272D0 SE9803272A SE9803272A SE9803272D0 SE 9803272 D0 SE9803272 D0 SE 9803272D0 SE 9803272 A SE9803272 A SE 9803272A SE 9803272 A SE9803272 A SE 9803272A SE 9803272 D0 SE9803272 D0 SE 9803272D0
Authority
SE
Sweden
Prior art keywords
cell regeneration
drug
order
relates
improve cell
Prior art date
Application number
SE9803272A
Other languages
English (en)
Inventor
Kerstin Uvnaes-Moberg
Thomas Lundeberg
Original Assignee
Kerstin Uvnaes Moberg
Thomas Lundeberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kerstin Uvnaes Moberg, Thomas Lundeberg filed Critical Kerstin Uvnaes Moberg
Priority to SE9803272A priority Critical patent/SE9803272D0/sv
Publication of SE9803272D0 publication Critical patent/SE9803272D0/sv
Priority to JP2000571941A priority patent/JP2002525337A/ja
Priority to EP99952872A priority patent/EP1115416B1/en
Priority to CN99812672A priority patent/CN1330550A/zh
Priority to AT99952872T priority patent/ATE383166T1/de
Priority to AU64931/99A priority patent/AU6493199A/en
Priority to DE69937959T priority patent/DE69937959D1/de
Priority to PCT/SE1999/001713 priority patent/WO2000018424A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/095Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
SE9803272A 1998-09-25 1998-09-25 A drug for cell regeneration SE9803272D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE9803272A SE9803272D0 (sv) 1998-09-25 1998-09-25 A drug for cell regeneration
JP2000571941A JP2002525337A (ja) 1998-09-25 1999-09-27 細胞再生をもたらすオキシトシン活性物質の使用
EP99952872A EP1115416B1 (en) 1998-09-25 1999-09-27 Use of substances with oxytocin activity in order to create cell regeneration
CN99812672A CN1330550A (zh) 1998-09-25 1999-09-27 具有催产素活性的物质在引起细胞再生中的应用
AT99952872T ATE383166T1 (de) 1998-09-25 1999-09-27 Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration
AU64931/99A AU6493199A (en) 1998-09-25 1999-09-27 Use of substances with oxytocin activity in order to create stimulate cell regeneration
DE69937959T DE69937959D1 (de) 1998-09-25 1999-09-27 Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration
PCT/SE1999/001713 WO2000018424A1 (en) 1998-09-25 1999-09-27 Use of substances with oxytocin activity in order to create cell regeneration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803272A SE9803272D0 (sv) 1998-09-25 1998-09-25 A drug for cell regeneration

Publications (1)

Publication Number Publication Date
SE9803272D0 true SE9803272D0 (sv) 1998-09-25

Family

ID=20412731

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803272A SE9803272D0 (sv) 1998-09-25 1998-09-25 A drug for cell regeneration

Country Status (8)

Country Link
EP (1) EP1115416B1 (sv)
JP (1) JP2002525337A (sv)
CN (1) CN1330550A (sv)
AT (1) ATE383166T1 (sv)
AU (1) AU6493199A (sv)
DE (1) DE69937959D1 (sv)
SE (1) SE9803272D0 (sv)
WO (1) WO2000018424A1 (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915625D0 (en) * 1999-07-02 1999-09-01 Cortendo Ab Method
SE0001440D0 (sv) * 2000-04-18 2000-04-18 Entretech Medical Ab A drug against climacteric disorders
SE0100684D0 (sv) 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter
SE0102185D0 (sv) * 2001-06-19 2001-06-19 Uvnaes Moberg Kerstin New subject-matter
SE0102910D0 (sv) * 2001-08-31 2001-08-31 Moberg Kerstin Uvnaes New use
ES2315455T3 (es) * 2003-03-27 2009-04-01 Pantarhei Bioscience B.V. Uso de estrogenos para el tratamiento de infertilidad en maniferos machos.
SE536091C2 (sv) 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
DE102011118016A1 (de) * 2011-10-26 2013-05-02 Henkel Ag & Co. Kgaa Kosmetische Mittel enthaltend Oxytocin und Riechstoffe
RU2544462C1 (ru) * 2013-11-29 2015-03-20 Федеральное государственное бюджетное учреждение "Государственный научный центр Российской Федерации-Федеральный медицинский биофизический центр имени А.И. Бурназяна Федерального медико-биологического агентства" (ФГБУ "ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА России") Способ профилактики развития острого панкреатита после операций на органах брюшной полости
US11414459B2 (en) 2017-09-28 2022-08-16 Kinoxis Therapeutics Pty Ltd Metabolite inspired selective oxytocin receptor agonists
JP7103886B2 (ja) * 2017-12-14 2022-07-20 花王株式会社 肌の質感改善剤の探索方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4312913A1 (de) * 1992-10-23 1994-10-13 Knauf Siegfried Medikamentenzusammensetzung Oxytocin, Vasopressin und alphabetagamma-Endorphine
DE4236293A1 (en) * 1992-10-23 1993-03-04 Siegfried Knauf Use of oxytocin, vasopressin and endorphins - for treatment and prevention of e.g. immunological, neurological and organ diseases and conditions caused by pituitary disorder
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II

Also Published As

Publication number Publication date
WO2000018424A1 (en) 2000-04-06
AU6493199A (en) 2000-04-17
EP1115416A1 (en) 2001-07-18
JP2002525337A (ja) 2002-08-13
ATE383166T1 (de) 2008-01-15
DE69937959D1 (de) 2008-02-21
EP1115416B1 (en) 2008-01-09
CN1330550A (zh) 2002-01-09

Similar Documents

Publication Publication Date Title
BR9807848B1 (pt) Composto de arilsulfonamidas e análogos, bem como composição farmacêutica e uso dos mesmos.
BRPI9907866B8 (pt) composição farmacêutica, bem como seu uso
TR199902383T2 (xx) Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses.
TR200103428T2 (tr) IMPDH enzim inhibitörleri.
DE69928085D1 (de) Dosierungsform mit verlängerter wirkstoffabgabe
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
EE04450B1 (et) Farmatseutilised kompositsioonid kahe või enama toimeainega aerosoolidele
DK0876815T3 (da) Lægemiddel-indgivelsessystem for to eller flere aktive stoffer
FR2715847B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
NO20011036D0 (no) Bipolar elektrode for elektrokjemiske redoks-reaksjoner
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
DE69931925D1 (de) 2-chinolonen enthaltende arzneimittel
DK1156806T3 (da) Farmaceutisk sammensætning indeholdende protonpumpeinhibitor
ATE243196T1 (de) Piperidine und pyrrolidine
SE9803272D0 (sv) A drug for cell regeneration
FR2774687B1 (fr) Lipopeptides contenant un fragment de l'interferon gamma, et leur utilisation dans des compositions pharmaceutiques
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
EE04055B1 (et) Ühendid ja kompositsioonid seriinproteaasse, eriti trüptaasse aktiivsusega seotud haiguste raviks, ja nende kasutamine
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
IL139318A0 (en) Sugar alcohol mixtures as therapeutic agents and pharmaceutical compositions containing the same
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
DE60133050D1 (de) Verwendung von substanzen mit oxytocin aktivität gegen klimakterische beschwerden
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
SE0102910D0 (sv) New use
EA200100098A1 (ru) Соли пароксетина